Cleared Traditional

Prudent 1717, Prudent 1417, Prudent 1212 (K211108) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K211108 · Pixxgen Corporation · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2021
Decision
51d
Days
Class 2
Risk

K211108 is an FDA 510(k) clearance for the Prudent 1717, Prudent 1417, Prudent 1212. Classified as Solid State X-ray Imager (flat Panel/digital Imager) (product code MQB), Class II - Special Controls.

Submitted by Pixxgen Corporation (Anyang-Si, KR). The FDA issued a Cleared decision on June 4, 2021 after a review of 51 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1680 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Pixxgen Corporation devices

Submission Details

510(k) Number K211108 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 14, 2021
Decision Date June 04, 2021
Days to Decision 51 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
56d faster than avg
Panel avg: 107d · This submission: 51d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MQB Solid State X-ray Imager (flat Panel/digital Imager)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1680
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Kamm & Associates
Daniel Kamm

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MQB Solid State X-ray Imager (flat Panel/digital Imager)

All 146
Devices cleared under the same product code (MQB) and FDA review panel - the closest regulatory comparables to K211108.
6543Z, 4386Z, 4343Z, 4343ZF, 3543Z, 3543ZF, 3030Z, 3025Z, 3025ZF
K212105 · Pzmedical Technology Co., Ltd. · Aug 2021
DX-D Imaging Package with XD Detectors
K211790 · Agfa N.V. · Jul 2021
PRIMO S
K211542 · A.T.S. Applicazione Tecnologie Speciali S.R.L. · Jul 2021
AcuityDRe
K210919 · Radmedix, LLC · Apr 2021
1717FCC
K210985 · Rayence Co., Ltd. · Apr 2021
Yushan X-Ray Flat Panel Detector with DROC
K210988 · Innocare Optoelectronics Corp. · Apr 2021